Chrome Extension
WeChat Mini Program
Use on ChatGLM

Table S1 from Tissue and Plasma EGFR Mutation Analysis in the FLAURA Trial: Osimertinib versus Comparator EGFR Tyrosine Kinase Inhibitor as First-Line Treatment in Patients with EGFR-Mutated Advanced Non–Small Cell Lung Cancer

crossref(2023)

Cited 0|Views5
No score
Abstract
Table S1 gives a summary of all screened patients with uncommon EGFR mutations detected by the central cobas® EGFR Mutation Test
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined